MEF2C and acute lymphoblastic leukemia: MEF2C expression levels correlate with BCL2 and LMO2 expression levels in patients with ETP-ALL but not in other patients with T-ALL (Supplemental Figure 1F), and it is validated for LMO2 in the original data set as published by Homminga et al. (5) (Supplemental Figure 1G).